These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12019075)

  • 1. Antimicrobial activity of a novel catheter lock solution.
    Shah CB; Mittelman MW; Costerton JW; Parenteau S; Pelak M; Arsenault R; Mermel LA
    Antimicrob Agents Chemother; 2002 Jun; 46(6):1674-9. PubMed ID: 12019075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ML8-X10 (a prototype oil-in-water micro-emulsion based on a novel free fatty acid), taurolidine/citrate/heparin and vancomycin/heparin antimicrobial lock solutions in the eradication of biofilm-producing staphylococci from central venous catheters.
    Luther MK; Mermel LA; LaPlante KL
    J Antimicrob Chemother; 2014 Dec; 69(12):3263-7. PubMed ID: 25096074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Assessment of the Antimicrobial Efficacy of Optimized Nitroglycerin-Citrate-Ethanol as a Nonantibiotic, Antimicrobial Catheter Lock Solution for Prevention of Central Line-Associated Bloodstream Infections.
    Reitzel RA; Rosenblatt J; Hirsh-Ginsberg C; Murray K; Chaftari AM; Hachem R; Raad I
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5175-81. PubMed ID: 27297475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of taurolidine citrate versus heparin as catheter lock solution in paediatric patients with haematological malignancies.
    Dümichen MJ; Seeger K; Lode HN; Kühl JS; Ebell W; Degenhardt P; Singer M; Geffers C; Querfeld U
    J Hosp Infect; 2012 Apr; 80(4):304-9. PubMed ID: 22342714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
    Betjes MG; van Agteren M
    Nephrol Dial Transplant; 2004 Jun; 19(6):1546-51. PubMed ID: 14993498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of hemodialysis catheter lock solutions in relation to other compounds with antiseptic properties.
    Piątkowska E; Paleczny J; Dydak K; Letachowicz K
    PLoS One; 2021; 16(10):e0258148. PubMed ID: 34618850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EDTA and Taurolidine Affect Pseudomonas aeruginosa Virulence
    Colombari B; Alfano G; Gamberini C; Cappelli G; Blasi E
    Microbiol Spectr; 2021 Dec; 9(3):e0104721. PubMed ID: 34787464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiocidal effects of various taurolidine containing catheter lock solutions.
    Olthof ED; Nijland R; Gülich AF; Wanten GJ
    Clin Nutr; 2015 Apr; 34(2):309-14. PubMed ID: 24861410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
    Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
    Trials; 2018 May; 19(1):264. PubMed ID: 29720244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Taurolidine-Citrate-Heparin Lock Solution Effectively Eradicates Pathogens From the Catheter Biofilm in Hemodialysis Patients.
    Zwiech R; Adelt M; Chrul S
    Am J Ther; 2016; 23(2):e363-8. PubMed ID: 23665885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurolidine and Heparin as Catheter Lock Solution for Central Venous Catheters in Hemodialysis.
    Nguyen T; Camins BC; Butler DA
    Am J Ther; 2024 Jul-Aug 01; 31(4):e398-e409. PubMed ID: 38710029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taurolidine/Citrate Lock Therapy for Primary Prevention of Catheter-Related Infections in Cancer Patients: Results of a Prospective, Randomized, Phase IV Trial (ATAPAC).
    Longo R; Llorens M; Goetz C; Platini C; Eid N; Sellies J; Ouamara N; Quétin P
    Oncology; 2017; 93(2):99-105. PubMed ID: 28463827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of taurolidine on single species and a multispecies population associated with periodontitis.
    Zollinger L; Schnyder S; Nietzsche S; Sculean A; Eick S
    Anaerobe; 2015 Apr; 32():18-23. PubMed ID: 25460194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of taurolidine gel on bacteria associated with periodontitis.
    Eick S; Gloor N; Püls C; Zumbrunn J; Sculean A
    Clin Oral Investig; 2016 Apr; 20(3):597-606. PubMed ID: 26254142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
    Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biofilm formation in long-term central venous catheters in children with cancer: a randomized controlled open-labelled trial of taurolidine versus heparin.
    Handrup MM; Fuursted K; Funch P; Møller JK; Schrøder H
    APMIS; 2012 Oct; 120(10):794-801. PubMed ID: 22958287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmarketing experience with Neutrolin® (taurolidine, heparin, calcium citrate) catheter lock solution in hemodialysis patients.
    Reidenberg BE; Wanner C; Polsky B; Castanheira M; Shelip A; Stalleicken D; Pfaffle AE
    Eur J Clin Microbiol Infect Dis; 2018 Apr; 37(4):661-663. PubMed ID: 29214504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of microbial adaptation to taurolidine in patients on home parenteral nutrition who develop catheter related bloodstream infections and use taurolidine locks.
    Olthof ED; Rentenaar RJ; Rijs AJ; Wanten GJ
    Clin Nutr; 2013 Aug; 32(4):538-42. PubMed ID: 23267744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions.
    Olthof ED; Versleijen MW; Huisman-de Waal G; Feuth T; Kievit W; Wanten GJ
    PLoS One; 2014; 9(11):e111216. PubMed ID: 25379781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of locking solutions on conditioning biofilm formation in tunnelled haemodialysis catheters and inflammatory response activation.
    Jiménez Hernández M; Soriano A; Filella X; Calvo M; Coll E; Rebled JM; Poch E; Graterol F; Compte MT; Maduell F; Fontsere N
    J Vasc Access; 2021 May; 22(3):370-379. PubMed ID: 32691665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.